ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BTAI BioXcel Therapeutics Inc

2.56
-0.03 (-1.16%)
Last Updated: 14:56:54
Delayed by 15 minutes

BioXcel Therapeutics Financial Summary

The current BTAI market cap is 74.94M. The company's latest EPS is USD -6.1167 and P/E is -0.42.

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 137k238k206k457k341k
Operating Income -38.98M-52.89M-51.2M-52.41M-48.3M
Net Income -41.81M-54.81M-52.8M-53.52M-50.49M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 000375k1.38M
Operating Income -33.6M-82.3M-106.94M-159.65M-171.78M
Net Income -32.97M-82.17M-106.93M-165.76M-179.05M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 244.82M205.85M180.1M140.1M100.45M
Total Liabilities 117.83M129.08M127.1M134.23M141.06M
Total Equity 126.99M76.78M53.01M5.86M-40.61M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 36.39M219.94M239.44M205.85M73.7M
Total Liabilities 9.5M13.24M17.77M129.08M130.21M
Total Equity 26.9M206.7M221.67M76.78M-56.51M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -96.7M-135.34M-52.35M-90.56M-128.14M
Investing -139k-139k N/A -20k-20k
Financing 96.19M96.24M24.15M24.4M24.4M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -27.28M-66.35M-82.15M-135.34M-155.01M
Investing -870k-316k-445k-139k-20k
Financing 18.01M247.36M102.45M96.24M26.52M
Market Cap 74.94M
Price to Earnings Ratio -0.42
Price to Sales Ratio 54.35
Price to Cash Ratio 1.15
Price to Book Ratio -1.33
Dividend Yield -

Share Statistics

Shares Outstanding 29.27M
Average Volume (1 week) 499.59k
Average Volume (1 Month) 445.92k
52 Week Change -88.15%
52 Week High 29.56
52 Week Low 1.91
Spread (Intraday) 0.01 (0.39%)

Company Info

Company Name BioXcel Therapeutics Inc
Address 251 little falls drive
wilmington, delaware 19808
Website https://www.bioxceltherapeutics.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock